Although miR-625 targeting IGF2BP1 has been shown to be frequently downregulated in conventional HCC [27], this miR was deleted in fewer than 5% of our FL-HCC specimens. The gene discussed is IGF2BP1; the disease is hepatocellular carcinoma.